Both in Surgical Instruments
Neuropace vs Cerus
Over the past year NPCE returned +36.1% and CERS returned +62.5%; their daily moves had a correlation of 0.27.
NPCE +36.1% CERS +62.5%Growth of $1, one year, split-adjusted
| Metric | NPCE | CERS |
|---|---|---|
| Price | $13.94 | $2.47 |
| Market cap | $478.5M | $497.8M |
| Today | −1.48% | +0.82% |
| 1 month | −3.3% | −6.8% |
| 6 months | +8.6% | +42.8% |
| Year to date | −9.7% | +19.9% |
| 1 year | +36.7% | +71.5% |
| Revenue growth (YoY) | +17.1% | +5.3% |
| Gross margin | 82.8% | 55.9% |
| Net margin | −27.2% | −4.6% |
| P/E (TTM) | — | — |
| Price / sales | 4.8× | 2.0× |
| Net cash | -$7.3M | -$8.7M |
| Dividend yield | — | — |
| Volatility (60d) | 50.6% | 75.8% |
| Short % of float | 4.0% | 9.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).